Medical Director, Advanced Heart Failure Program
MedStar Health, Georgetown University School of Medicine
Washington, District of Columbia, United States
Dr. Farooq Sheikh is the Medical Director of the Advanced Heart Failure and LVAD Programs at the MedStar Heart and Vascular Institute (Washington Region). He is the Regional Director of MedStar Health’s Infiltrative Cardiomyopathy Program focused on the comprehensive care of patients with cardiac amyloidosis and sarcoidosis. Dr. Sheikh is an Associate Professor of Medicine at the Georgetown University School of Medicine.
Dr. Sheikh’s clinical and research interests lie in the outcomes of patients with LVAD therapy and infiltrative heart disease. He has served as MedStar’s principal investigator for a number of clinical trials including the MOMENTUM 3 Clinical Trial Portfolio, HELIOS B, and the CARDIO-TTRansform.
Sunday, February 26, 2023
12:00 PM – 12:08 PM ET
Disclosure(s): Abbott Laboratories: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker for educational conference (Ongoing); Alnylam: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Ionis: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
Sunday, February 26, 2023
12:24 PM – 12:35 PM ET
Disclosure(s): Abbott Laboratories: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker for educational conference (Ongoing); Alnylam: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Ionis: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
Tuesday, February 28, 2023
7:45 AM – 1:00 PM ET
Disclosure(s): Abbott Laboratories: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker for educational conference (Ongoing); Alnylam: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Ionis: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
Tuesday, February 28, 2023
9:30 AM – 10:42 AM ET
Disclosure(s): Abbott Laboratories: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker for educational conference (Ongoing); Alnylam: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Ionis: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
Tuesday, February 28, 2023
9:42 AM – 9:54 AM ET
Disclosure(s): Abbott Laboratories: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker for educational conference (Ongoing); Alnylam: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Ionis: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)